The impact of pulse generator longevity on the long-term costs of cardiac pacing

PACE - Pacing and Clinical Electrophysiology

Volumn 19, Issue 10, 1996, Pages 1459-1468

  Gillis, Anne M ^a,c   MacQuarrie, David S ^b   Wilson, Suzanne L ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Medtronic of Canada Ltd   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

cardiac pacing; cost of pacing; pulse generator longevity

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEVICE; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE SYSTEM; HEART PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; PULSE GENERATOR; SURVIVAL;

ACTUARIAL ANALYSIS; AGED; ARRHYTHMIA; ELECTRIC POWER SUPPLIES; FEMALE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 0029792462     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1996.tb03159.x     Document Type: Article

References (28)

1. Eagle KA, Mulley AG, Singer DE, et al. Single-chamber and dual-chamber cardiac pacemakers. A formal cost comparison. Ann Intern Med 1986; 105:264-271.
2. The history of cardiac pacing. In R Sutton, I Bourgeois (eds.): The Foundations of Cardiac Pacing, Pt. I: An Illustrated Practical Guide to Basic Pacing. Mount Kisco, NY, Futura Publishing Co., 1991, pp. 319-324.
3. Furman S. Pacemaker longevity. PACE 1989; 12:1437-1438.
4. Markewitz A, Kronski D, Kammeyer A, et al. Adequate pulse generator selection increases cost-effectiveness in pacemaker therapy. PACE 1993; 16(Part II):882.
5. Schuchert A, Kuck K-H. Influence of internal current and pacing current on pacemaker longevity. PACE 1994; 17:13-16.
6. Bernstein AD, Parsonnet V. Engineering aspects of pulse generators for cardiac pacing. In S Saksena, N Goldschlager (eds.): Electrical Therapy for Cardiac Arrhythmias. Philadelphia, WB Saunders Co., 1990, pp. 21-34.
7. Simon AB, Janz N. Symptomatic bradyarrhythmias in the adult: Natural history following pacemaker implantation. PACE 1982; 5:372-383.
8. Alt E, Volker R, Wirtzfeld A, et al. Survival and follow-up after pacemaker implantation: A comparison of patients with sick sinus syndrome, complete heart block, and atrial fibrillation. PACE 1985; 8:849-855.
9. Zanini R, Facchinetti A, Gallo G, et al. Survival rates after pacemaker implantation: A study of patients paced for sick sinus syndrome and atrioventricular block. PACE 1989; 12:1065-1069.
10. Jelic V, Belkic K, Djordjevic M, et al. Survival in 1431 pacemaker patients: Prognostic factors and comparison with the general population. PACE 1992; 15:141-147.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
12. Kim J, Keenan T. Medtronic IPG longevity forecasting. Medtronic IPG Longevity Forecast 1991:1-4.
13. IMS America, Copyright 1993.
14. Brennen KR, Kim JS. Battery performance modelling. In B Owens (ed.): Batteries for Implantable Biomedical Devices. New York, Plenum Press, 1986, pp. 113-131.
15. Fee schedule for physicians and services for calendar year 1993, Federal Register, November 25, 1992.
16. Bernstein AD, Irwin ME, Parsonnet V, et al. Report of the NASPE policy conference on antibradycardia pacemaker follow-up: Effectiveness, needs, and resources. PACE 1994; 17:1714-1727.
17. Bernstein Research. The future of health-care delivery in America. Sanford C. Bernstein and Co., Inc., Copyright 1993.
18. Angell M. How much will health care reform cost? N Engl J Med 1993; 328:1778-1779.
19. Starr P. The framework of health care reform. N Engl J Med 1993; 329:1666-1672.
20. Wyse DG, Gillis AM. Funding for cardiac pacing and defibrillators in Calgary: The Robin Hood philosophy. PACE 1993; 16:2305-2309.
21. Ray SG, Griffith MJ, Jamieson S, et al. Impact of the recommendations of the British Pacing and Electrophysiology Group on pacemaker prescription and on the immediate costs of pacing in the Northern Region. Br Heart J 1992; 68:531-534.
22. deBelder MA, Linker NJ, Jones S, et al. Cost implications of the British Pacing and Electrophysiology Group's recommendations for pacing. Br Med J 1992; 305:861-865.
23. Cazeau S, Ritter P, Duconjé R, et al. Pacemaker size reduction: What is the limit? PACE 1994; 17:818.
24. Gillis AM, Rothschild JM, Hillier K, et al. A randomized comparison of a bipolar steroid-eluting electrode and a bipolar microporous platinum electrode: Implications for long-term programming. PACE 1993; 16:964-970.
25. Song SL. The Bilitch Report: Performance of implantable cardiac rhythm management devices. PACE 1994; 17:692-708.
26. Bernstein AD, Parsonnet V. Survey of cardiac pacing in the United States in 1989. Am J Cardiol 1992; 64:331-338.
27. Stokes K, Bird T. A new efficient nanotip lead. PACE 1990; 13:1901-1905.
28. Bernsohn MM, Panzer SB, Prest-Berg K. Electrical characteristics of third generation steroid-eluting pacing leads: Potential for a 17-year pacemaker battery life. PACE 1994; 17:854.